(a) El Ashry, E.S.H.; Rashed, N. 1,2,3-Triazolo[x, y-z]pyrimidines.
Adv. Heterocycl. Chem., 1998,
71, 57-114.
[
http://dx.doi.org/10.1016/S0065-2725(08)60831-4 ]
(b) Fischer, G. Recent progress in 1,2,4-triazolo[1,5-a]pyrimidine chemistry.
Adv. Heterocycl. Chem., 2008,
95, 143-219.
[
http://dx.doi.org/10.1016/S0065-2725(07)95003-5 ]
(c) Ohnishi, H.; Yamaguchi, K.; Shimada, S.; Suzuki, Y.; Kumagai, A. A new approach to the treatment of atherosclerosis and trapidil as an antagonist to platelet-derived growth factor.
Life Sci., 1981,
28(14), 1641-1646.
[
http://dx.doi.org/10.1016/0024-3205(81)90320-9] [PMID:
6264257 ]
(d) Novinson, T.; Springer, R.H. OíBrien, D.E.; Scholten, M.B.; Miller, J.P.; Robins, R.K. 2-(Alkylthio)-1,2,4-triazolo[1,5-a]pyrimidines as adenosine 3′,5′-monophosphate phosphodiesterase inhibitors with potential as new cardiovascular agents.
J. Med. Chem., 1982,
25, 420-426.
[
http://dx.doi.org/10.1021/jm00346a017] [PMID:
6279846]
(e) Gujjar, R.; Marwaha, A.; El Mazouni, F.; White, J.; White, K.L.; Creason, S.; Shackleford, D.M.; Baldwin, J.; Charman, W.N.; Buckner, F.S.; Charman, S.; Rathod, P.K.; Phillips, M.A. Identification of a metabolically stable triazolopyrimidine-based dihydroorotate dehydrogenase inhibitor with antimalarial activity in mice.
J. Med. Chem., 2009,
52(7), 1864-1872.
[
http://dx.doi.org/10.1021/jm801343r] [PMID:
19296651]
(f) Chen, Q.; Zhu, X.L.; Jiang, L.L.; Liu, Z.M.; Yang, G.F. Synthesis, antifungal activity and CoMFA analysis of novel 1,2,4-triazolo[1,5-a]pyrimidine derivatives.
Eur. J. Med. Chem., 2008,
43(3), 595-603.
[
http://dx.doi.org/10.1016/j.ejmech.2007.04.021] [PMID:
17618711 ]
(g) Yu, W.; Goddard, C.; Clearfield, E.; Mills, C.; Xiao, T.; Guo, H.; Morrey, J.D.; Motter, N.E.; Zhao, K.; Block, T.M.; Cuconati, A.; Xu, X. Design, synthesis, and biological evaluation of triazolo-pyrimidine derivatives as novel inhibitors of hepatitis B virus surface antigen (HBsAg) secretion.
J. Med. Chem., 2011,
54(16), 5660-5670.
[
http://dx.doi.org/10.1021/jm200696v] [PMID:
21786803 ]
(h) El-Gendy, M.M.A.; Shaaban, M.; Shaaban, K.A.; El-Bondkly, A.M.; Laatsch, H. Essramycin: A first triazolopyrimidine antibiotic isolated from nature.
J. Antibiot. (Tokyo), 2008,
61(3), 149-157.
[
http://dx.doi.org/10.1038/ja.2008.124] [PMID:
18503193 ]
(i)Allen, J.G.; Bourbeau, M.P.; Wohlhieter, G.E.; Bartberger, M.D.; Michelsen, K.; Hungate, R.; Gadwood, R.C.; Gaston, R.D.; Evans, B.; Mann, L.W.; Matison, M.E.; Schneider, S.; Huang, X.; Yu, D.; Andrews, P.S.; Reichelt, A.; Long, A.M.; Yakowec, P.; Yang, E.Y.; Lee, T.A.; Oliner, J.D. Discovery and optimization of chromenotriazolopyrimidines as potent inhibitors of the mouse double minute 2-tumor protein 53 protein-protein interaction.
J. Med. Chem., 2009,
52(22), 7044-7053.
[
http://dx.doi.org/10.1021/jm900681h] [PMID:
19856920 ]
(j)Tang, W.; Shi, D.Q. Synthesis and herbicidal activity of O,O-dialkyl N-[2-(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yloxy)benzoxyl]-1-amino-1-substitutedbe-nzyl phosphonates.
J. Heterocycl. Chem., 2010,
47, 162-166.
(k)Chen, Q.; Liu, Z.M.; Chen, C.N.; Jiang, L.L.; Yang, G.F. Synthesis and fungicidal activities of new 1,2,4-triazolo[1,5-a]pyrimidines.
Chem. Biodivers., 2009,
6(8), 1254-1265.
[
http://dx.doi.org/10.1002/cbdv.200800168] [PMID:
19697344 ]
(l)El-Koussi, N.A.; Omar, F.A.; Abdel-Aziz, S.A.; Radwan, M.F. Synthesis and antibacterial screening of some 2, 5, 7-triaryl-1, 2, 4-triazolo.
Pyrimidines. Bull. Pharm. Sci., 2004,
27, 141-154.
(m)Lakomska, I.; Wojtczak, A.; Sitkowski, J.; Kozerski, L.; Szlyk, E. Platinum(IV) complexes with purine analogs. Studies of molecular structure and antiproliferative activity
in vitro. Polyhedron, 2008,
27, 2765-2770.
[
http://dx.doi.org/10.1016/j.poly.2008.05.032 ]
(n)Lakomska, I. Molecular structure and antitumor activity of platinum(II) complexes containing purine analogs.
Inorg. Chim. Acta, 2009,
362, 669-681. http://
[
http://dx.doi.org/10.1016/j.ica.2008.02.030]